Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.51)
# 901
Out of 5,012 analysts
520
Total ratings
42.8%
Success rate
7.27%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $19 | $11.91 | +59.53% | 28 | Oct 8, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $33 → $36 | $19.87 | +81.18% | 16 | Oct 7, 2025 | |
| ICCM IceCure Medical | Maintains: Buy | $2 → $2.5 | $0.99 | +152.22% | 23 | Oct 7, 2025 | |
| RGNX REGENXBIO | Reiterates: Buy | $34 | $12.22 | +178.23% | 13 | Oct 7, 2025 | |
| VNRX VolitionRx | Reiterates: Buy | $2.5 | $0.65 | +285.80% | 3 | Sep 30, 2025 | |
| AXGN Axogen | Initiates: Buy | $25 | $17.16 | +45.69% | 1 | Sep 30, 2025 | |
| HROW Harrow | Reiterates: Buy | $64 | $39.74 | +61.05% | 6 | Sep 29, 2025 | |
| KALA KALA BIO | Downgrades: Neutral | n/a | $1.57 | - | 24 | Sep 29, 2025 | |
| OKYO OKYO Pharma | Reiterates: Buy | $7 | $2.24 | +212.50% | 14 | Sep 23, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $100 → $98 | $77.88 | +25.83% | 21 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $98 | $103.25 | -5.08% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.44 | +57.66% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $48 | $47.89 | +0.23% | 8 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.90 | +244.83% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $4.17 | +115.83% | 19 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.73 | +266.30% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.38 | +189.86% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.87 | +213.59% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.16 | +153.16% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $1.98 | +455.56% | 2 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $54 | $32.33 | +67.05% | 5 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.45 | +131.88% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $32 | $27.34 | +17.04% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $13 | $6.64 | +95.78% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $13.88 | +65.71% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.48 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $14.71 | +8.77% | 19 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.91 | +339.71% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $4.40 | +1,604.55% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $11.12 | +43.88% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $2.72 | +83.82% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $11.13 | +61.73% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $14.79 | +69.03% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $11.45 | +240.76% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.55 | +93.55% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.68 | +339.75% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.39 | +153.81% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.51 | +98.68% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.41 | +580.27% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.60 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.24 | +3,993.33% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.52 | +2,034.26% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.14 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $12.38 | +287.72% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $49.50 | -61.62% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.39 | - | 2 | Apr 16, 2020 |
Ocular Therapeutix
Oct 8, 2025
Maintains: Buy
Price Target: $15 → $19
Current: $11.91
Upside: +59.53%
Oculis Holding AG
Oct 7, 2025
Maintains: Buy
Price Target: $33 → $36
Current: $19.87
Upside: +81.18%
IceCure Medical
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.99
Upside: +152.22%
REGENXBIO
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $12.22
Upside: +178.23%
VolitionRx
Sep 30, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.65
Upside: +285.80%
Axogen
Sep 30, 2025
Initiates: Buy
Price Target: $25
Current: $17.16
Upside: +45.69%
Harrow
Sep 29, 2025
Reiterates: Buy
Price Target: $64
Current: $39.74
Upside: +61.05%
KALA BIO
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
OKYO Pharma
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.24
Upside: +212.50%
Belite Bio
Sep 15, 2025
Maintains: Buy
Price Target: $100 → $98
Current: $77.88
Upside: +25.83%
Sep 12, 2025
Maintains: Buy
Price Target: $90 → $98
Current: $103.25
Upside: -5.08%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $4.44
Upside: +57.66%
Sep 10, 2025
Downgrades: Neutral
Price Target: $50 → $48
Current: $47.89
Upside: +0.23%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.90
Upside: +244.83%
Sep 3, 2025
Reiterates: Buy
Price Target: $9
Current: $4.17
Upside: +115.83%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.73
Upside: +266.30%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.38
Upside: +189.86%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $2.87
Upside: +213.59%
Aug 20, 2025
Reiterates: Buy
Price Target: $8
Current: $3.16
Upside: +153.16%
Aug 18, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $1.98
Upside: +455.56%
Aug 18, 2025
Maintains: Buy
Price Target: $53 → $54
Current: $32.33
Upside: +67.05%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.45
Upside: +131.88%
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $32
Current: $27.34
Upside: +17.04%
Aug 7, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $6.64
Upside: +95.78%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $13.88
Upside: +65.71%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.48
Upside: -
Jul 31, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $14.71
Upside: +8.77%
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.91
Upside: +339.71%
Jul 18, 2025
Downgrades: Neutral
Price Target: $75
Current: $4.40
Upside: +1,604.55%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $11.12
Upside: +43.88%
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.72
Upside: +83.82%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $11.13
Upside: +61.73%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $14.79
Upside: +69.03%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $11.45
Upside: +240.76%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.55
Upside: +93.55%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.68
Upside: +339.75%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.39
Upside: +153.81%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.51
Upside: +98.68%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $4.41
Upside: +580.27%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.60
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.24
Upside: +3,993.33%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.52
Upside: +2,034.26%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.14
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $12.38
Upside: +287.72%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $49.50
Upside: -61.62%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.39
Upside: -